As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 2/14/22  Balyasny Asset Management L.P.    SC 13G/A               1:288K Dicerna Pharmaceuticals Inc.      Donnelley … Solutions/FA 
          Atlas Diversified Fund, L.P.³
          Atlas Diversified Fund, Ltd.³
          Atlas Diversified Master Fund, Ltd.³
          Atlas Enhanced Fund, LP³
          Atlas Enhanced Fund, Ltd.³
          Atlas Enhanced Master Fund, Ltd.³
          Atlas Global Investments, Ltd.³
          Atlas Global, LLC³
          Atlas Institutional Equity Fund, LP³
          Atlas Master Fund, Ltd.³
          Atlas Portable Alpha, LP³
          Dmitry Balyasny³
 12/3/21  Balyasny Asset Management L.P.    SC 13G                 1:270K Dicerna Pharmaceuticals Inc.      Donnelley … Solutions/FA 
          Atlas Diversified Fund, L.P.³
          Atlas Diversified Fund, Ltd.³
          Atlas Diversified Master Fund, Ltd.³
          Atlas Enhanced Fund, LP³
          Atlas Enhanced Fund, Ltd.³
          Atlas Enhanced Master Fund, Ltd.³
          Atlas Global Investments, Ltd.³
          Atlas Global, LLC³
          Atlas Institutional Equity Fund, LP³
          Atlas Master Fund, Ltd.³
          Atlas Portable Alpha, LP³
          Dmitry Balyasny³

____________
¹	Filing/Form Type:  /A
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.